反应 #674299

ord-5da05256bf684a199f4b4b90ac122670

反应方程式

C=C1CCN(C(=O)OC(C)(C)C)CC1
tert-butyl 4-methylenepiperidine-1-carboxylate
O=C(Cl)C(Cl)(Cl)Cl
2,2,2-trichloroacetyl chloride
[Cl-].[NH4+]
NH4Cl
N#N
N2
CC(C)(C)OC(=O)N1CCC2(CC1)CC(=O)C2
tert-butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate
收率 15.0%

反应条件

温度
15°CELSIUS
详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    其他To the mixture thus obtained
  2. 2
    workup.STIRRINGThe mixture was stirred at room temperature overnight
  3. 3
    workup.ADDITIONafter addition
  4. 4
    workup.STIRRINGTo the reaction mixture stirred in an external ice-bath
  5. 5
    workup.ADDITIONAfter addition
  6. 6
    workup.STIRRINGthe mixture was stirred at room temperature for 4 h
  7. 7
    过滤filtered
  8. 8
    其他to remove the solid
  9. 9
    其他The phases were separated
  10. 10
    萃取The aqueous phase was extracted with EtOAc
  11. 11
    洗涤The combined organic phase was washed with brine
  12. 12
    干燥dried over anhydrous Na2SO4
  13. 13
    浓缩concentrated
  14. 14
    其他to give the residue which
  15. 15
    其他was purified by CombiFlash (40 g silica gel column, EtOAc/Hexane: 0-40%)

实验过程

To a flame-dried RB flask with tert-butyl 4-methylenepiperidine-1-carboxylate (2.96 g, 15 mmol, 1.0 equiv) and Zn/Cu couple (6.54 g, 172.5 mmol, 11.5 equiv) under vacuum, t-BuOMe (60 mL) was charged and refilled the flask with N2 balloon. To the mixture thus obtained stirred at 15° C., a solution of 2,2,2-trichloroacetyl chloride in DME (20 mL) was added dropwise. The mixture was stirred at room temperature overnight after addition. To the reaction mixture stirred in an external ice-bath, a saturated solution of NH4Cl (60 mL) was added slowly and carefully (especially the first few drops). After addition, the mixture was stirred at room temperature for 4 h, filtered to remove the solid. The phases were separated. The aqueous phase was extracted with EtOAc. The combined organic phase was washed with brine, dried over anhydrous Na2SO4, concentrated to give the residue which was purified by CombiFlash (40 g silica gel column, EtOAc/Hexane: 0-40%) to afford 619 mg (15%) of tert-butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate.

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US09226923B2uspto-grants-2016_01